NY-ESO-1 Peptide (SLLMWITQC)
| $160.00 | |
| RP30225 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
IVD Raw Materials
| $160.00 | |
| RP30225 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
| Description | SLLMWITQC is a linear peptidic epitope (epitope ID 59278) studied as part of Cancer/testis antigen 1 from Homo sapiens (human). This TCR-like antibody specifically targets to HumanNY-ESO-1 antigen that recognizes epitope SLLMWITQC presented on HLA-A*02:01. This product is mainly used to treat Melanoma. |
| Sequence |
{Ser}{Leu}{Leu}{Met}{Trp}{Ile}{Thr}{Gln}{Cys} |
| Sequence Shortening | SLLMWITQC |
| Molecular Weight | 1094.35 |
| Purity | >95% |
| Solubility | Soluble in Formic acid under 1mg/ml |
| Form | Lyophilized |
| Storage | Store at -20°C. Keep tightly closed. Store in a cool dry place. |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.